Professor Ibram X. Kendi is packing up shop and leaving Boston University, but the antiracism grift is not over yet. On ...
Ibram X. Kendi, founding director of the Boston University Center for Antiracist Research, is moving to Howard University and the center will be shutting down.
Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after more than a decade at the helm of Japan's biggest drugmaker as the company upped its full-year profit outlook. Julie ...
Atalanta Therapeutics is building on the growing attention around RNAi-based medicines with its $97 million Series B financing and plans to enter the clinic.
BioMed Realty, one of the biggest labspace owners in the Boston area, recently acquired 215 First St., 150 Second St. and 11 ...